Hotline: +86-18022463983    020-85206863

Global Animal Vaccines Market Research Report 2025

Published Date: 2025-08-30   |   Pages: 97   |   Tables: 93   |  Pharma & Healthcare

The global market for Animal Vaccines was valued at US$ 8665 million in the year 2024 and is projected to reach a revised size of US$ 11980 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Animal vaccines control the transmission diseases, thus providing protection to animal and human health.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 222%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Vaccines.
The Animal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco
Virbac
Vetoquinol
Phibro Animal Health
Hester Biosciences
Hipra
IDT Biologika
Biogenesis Bago
Tianjin Ringpu
China Animal Husbandry
Segment by Type
Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines
Segment by Application
Companion Animals
Cattle
Pigs
Poultry
Sheep
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Animal Vaccines Market Overview
1.1 Product Definition
1.2 Animal Vaccines by Type
1.2.1 Global Animal Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Conjugate Vaccines
1.2.7 Recombinant Vaccines
1.2.8 DNA Vaccines
1.3 Animal Vaccines by Application
1.3.1 Global Animal Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Companion Animals
1.3.3 Cattle
1.3.4 Pigs
1.3.5 Poultry
1.3.6 Sheep
1.4 Global Animal Vaccines Market Size Estimates and Forecasts
1.4.1 Global Animal Vaccines Revenue 2020-2031
1.4.2 Global Animal Vaccines Sales 2020-2031
1.4.3 Global Animal Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Animal Vaccines Market Competition by Manufacturers
2.1 Global Animal Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Animal Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Animal Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Animal Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Animal Vaccines, Date of Enter into This Industry
2.8 Global Animal Vaccines Market Competitive Situation and Trends
2.8.1 Global Animal Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Animal Vaccines Players Market Share by Revenue
2.8.3 Global Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Animal Vaccines Market Scenario by Region
3.1 Global Animal Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Animal Vaccines Sales by Region: 2020-2031
3.2.1 Global Animal Vaccines Sales by Region: 2020-2025
3.2.2 Global Animal Vaccines Sales by Region: 2026-2031
3.3 Global Animal Vaccines Revenue by Region: 2020-2031
3.3.1 Global Animal Vaccines Revenue by Region: 2020-2025
3.3.2 Global Animal Vaccines Revenue by Region: 2026-2031
3.4 North America Animal Vaccines Market Facts & Figures by Country
3.4.1 North America Animal Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Animal Vaccines Sales by Country (2020-2031)
3.4.3 North America Animal Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Vaccines Market Facts & Figures by Country
3.5.1 Europe Animal Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Animal Vaccines Sales by Country (2020-2031)
3.5.3 Europe Animal Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Animal Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Animal Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Animal Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal Vaccines Market Facts & Figures by Country
3.7.1 Latin America Animal Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Animal Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Animal Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Animal Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Animal Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Animal Vaccines Sales by Type (2020-2031)
4.1.1 Global Animal Vaccines Sales by Type (2020-2025)
4.1.2 Global Animal Vaccines Sales by Type (2026-2031)
4.1.3 Global Animal Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Animal Vaccines Revenue by Type (2020-2031)
4.2.1 Global Animal Vaccines Revenue by Type (2020-2025)
4.2.2 Global Animal Vaccines Revenue by Type (2026-2031)
4.2.3 Global Animal Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Animal Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Animal Vaccines Sales by Application (2020-2031)
5.1.1 Global Animal Vaccines Sales by Application (2020-2025)
5.1.2 Global Animal Vaccines Sales by Application (2026-2031)
5.1.3 Global Animal Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Animal Vaccines Revenue by Application (2020-2031)
5.2.1 Global Animal Vaccines Revenue by Application (2020-2025)
5.2.2 Global Animal Vaccines Revenue by Application (2026-2031)
5.2.3 Global Animal Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Animal Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Animal Vaccines Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Animal Vaccines Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Animal Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Company Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Animal Vaccines Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Virbac Animal Vaccines Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Vetoquinol
6.6.1 Vetoquinol Company Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vetoquinol Animal Vaccines Product Portfolio
6.6.5 Vetoquinol Recent Developments/Updates
6.7 Phibro Animal Health
6.7.1 Phibro Animal Health Company Information
6.7.2 Phibro Animal Health Description and Business Overview
6.7.3 Phibro Animal Health Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Phibro Animal Health Animal Vaccines Product Portfolio
6.7.5 Phibro Animal Health Recent Developments/Updates
6.8 Hester Biosciences
6.8.1 Hester Biosciences Company Information
6.8.2 Hester Biosciences Description and Business Overview
6.8.3 Hester Biosciences Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hester Biosciences Animal Vaccines Product Portfolio
6.8.5 Hester Biosciences Recent Developments/Updates
6.9 Hipra
6.9.1 Hipra Company Information
6.9.2 Hipra Description and Business Overview
6.9.3 Hipra Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hipra Animal Vaccines Product Portfolio
6.9.5 Hipra Recent Developments/Updates
6.10 IDT Biologika
6.10.1 IDT Biologika Company Information
6.10.2 IDT Biologika Description and Business Overview
6.10.3 IDT Biologika Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 IDT Biologika Animal Vaccines Product Portfolio
6.10.5 IDT Biologika Recent Developments/Updates
6.11 Biogenesis Bago
6.11.1 Biogenesis Bago Company Information
6.11.2 Biogenesis Bago Description and Business Overview
6.11.3 Biogenesis Bago Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biogenesis Bago Animal Vaccines Product Portfolio
6.11.5 Biogenesis Bago Recent Developments/Updates
6.12 Tianjin Ringpu
6.12.1 Tianjin Ringpu Company Information
6.12.2 Tianjin Ringpu Description and Business Overview
6.12.3 Tianjin Ringpu Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tianjin Ringpu Animal Vaccines Product Portfolio
6.12.5 Tianjin Ringpu Recent Developments/Updates
6.13 China Animal Husbandry
6.13.1 China Animal Husbandry Company Information
6.13.2 China Animal Husbandry Description and Business Overview
6.13.3 China Animal Husbandry Animal Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China Animal Husbandry Animal Vaccines Product Portfolio
6.13.5 China Animal Husbandry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Vaccines Industry Chain Analysis
7.2 Animal Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Vaccines Production Mode & Process Analysis
7.4 Animal Vaccines Sales and Marketing
7.4.1 Animal Vaccines Sales Channels
7.4.2 Animal Vaccines Distributors
7.5 Animal Vaccines Customer Analysis
8 Animal Vaccines Market Dynamics
8.1 Animal Vaccines Industry Trends
8.2 Animal Vaccines Market Drivers
8.3 Animal Vaccines Market Challenges
8.4 Animal Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Animal Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Animal Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Animal Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Animal Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Animal Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Animal Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Animal Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Animal Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Animal Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Animal Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Animal Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Animal Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Animal Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Animal Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Animal Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Animal Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Animal Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Animal Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Animal Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Animal Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Animal Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Animal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Animal Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Animal Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Animal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Animal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Animal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Animal Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Animal Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Animal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Animal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Animal Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Animal Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Animal Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Animal Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Animal Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Animal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Animal Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Animal Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Animal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Animal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Animal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Animal Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Animal Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Animal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Animal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Animal Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Animal Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Animal Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Animal Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Animal Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Animal Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Animal Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Animal Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Animal Vaccines Price (USD/Unit) by Type (2020-2025)
Table 59. Global Animal Vaccines Price (USD/Unit) by Type (2026-2031)
Table 60. Global Animal Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Animal Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Animal Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Animal Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Animal Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Animal Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Animal Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Animal Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Animal Vaccines Price (USD/Unit) by Application (2020-2025)
Table 69. Global Animal Vaccines Price (USD/Unit) by Application (2026-2031)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Zoetis Animal Vaccines Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Animal Health Company Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Merck Animal Health Animal Vaccines Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Boehringer Ingelheim Animal Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Elanco Company Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Elanco Animal Vaccines Product
Table 89. Elanco Recent Developments/Updates
Table 90. Virbac Company Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Virbac Animal Vaccines Product
Table 94. Virbac Recent Developments/Updates
Table 95. Vetoquinol Company Information
Table 96. Vetoquinol Description and Business Overview
Table 97. Vetoquinol Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Vetoquinol Animal Vaccines Product
Table 99. Vetoquinol Recent Developments/Updates
Table 100. Phibro Animal Health Company Information
Table 101. Phibro Animal Health Description and Business Overview
Table 102. Phibro Animal Health Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Phibro Animal Health Animal Vaccines Product
Table 104. Phibro Animal Health Recent Developments/Updates
Table 105. Hester Biosciences Company Information
Table 106. Hester Biosciences Description and Business Overview
Table 107. Hester Biosciences Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hester Biosciences Animal Vaccines Product
Table 109. Hester Biosciences Recent Developments/Updates
Table 110. Hipra Company Information
Table 111. Hipra Description and Business Overview
Table 112. Hipra Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Hipra Animal Vaccines Product
Table 114. Hipra Recent Developments/Updates
Table 115. IDT Biologika Company Information
Table 116. IDT Biologika Description and Business Overview
Table 117. IDT Biologika Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. IDT Biologika Animal Vaccines Product
Table 119. IDT Biologika Recent Developments/Updates
Table 120. Biogenesis Bago Company Information
Table 121. Biogenesis Bago Description and Business Overview
Table 122. Biogenesis Bago Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Biogenesis Bago Animal Vaccines Product
Table 124. Biogenesis Bago Recent Developments/Updates
Table 125. Tianjin Ringpu Company Information
Table 126. Tianjin Ringpu Description and Business Overview
Table 127. Tianjin Ringpu Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Tianjin Ringpu Animal Vaccines Product
Table 129. Tianjin Ringpu Recent Developments/Updates
Table 130. China Animal Husbandry Company Information
Table 131. China Animal Husbandry Description and Business Overview
Table 132. China Animal Husbandry Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. China Animal Husbandry Animal Vaccines Product
Table 134. China Animal Husbandry Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Animal Vaccines Distributors List
Table 138. Animal Vaccines Customers List
Table 139. Animal Vaccines Market Trends
Table 140. Animal Vaccines Market Drivers
Table 141. Animal Vaccines Market Challenges
Table 142. Animal Vaccines Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report


List of Figures
Figure 1. Product Picture of Animal Vaccines
Figure 2. Global Animal Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Animal Vaccines Market Share by Type: 2024 & 2031
Figure 4. Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. Conjugate Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. DNA Vaccines Product Picture
Figure 11. Global Animal Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Animal Vaccines Market Share by Application: 2024 & 2031
Figure 13. Companion Animals
Figure 14. Cattle
Figure 15. Pigs
Figure 16. Poultry
Figure 17. Sheep
Figure 18. Global Animal Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Animal Vaccines Market Size (2020-2031) & (US$ Million)
Figure 20. Global Animal Vaccines Sales (2020-2031) & (K Units)
Figure 21. Global Animal Vaccines Average Price (USD/Unit) & (2020-2031)
Figure 22. Animal Vaccines Report Years Considered
Figure 23. Animal Vaccines Sales Share by Manufacturers in 2024
Figure 24. Global Animal Vaccines Revenue Share by Manufacturers in 2024
Figure 25. Global 5 and 10 Largest Animal Vaccines Players: Market Share by Revenue in Animal Vaccines in 2024
Figure 26. Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Global Animal Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 28. North America Animal Vaccines Sales Market Share by Country (2020-2031)
Figure 29. North America Animal Vaccines Revenue Market Share by Country (2020-2031)
Figure 30. U.S. Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Canada Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Europe Animal Vaccines Sales Market Share by Country (2020-2031)
Figure 33. Europe Animal Vaccines Revenue Market Share by Country (2020-2031)
Figure 34. Germany Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. France Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. U.K. Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Italy Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Russia Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific Animal Vaccines Sales Market Share by Region (2020-2031)
Figure 40. Asia Pacific Animal Vaccines Revenue Market Share by Region (2020-2031)
Figure 41. China Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Taiwan Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Indonesia Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Thailand Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Malaysia Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Philippines Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Latin America Animal Vaccines Sales Market Share by Country (2020-2031)
Figure 52. Latin America Animal Vaccines Revenue Market Share by Country (2020-2031)
Figure 53. Mexico Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Brazil Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Argentina Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Animal Vaccines Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Animal Vaccines Revenue Market Share by Country (2020-2031)
Figure 58. Turkey Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. U.A.E Animal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Global Sales Market Share of Animal Vaccines by Type (2020-2031)
Figure 62. Global Revenue Market Share of Animal Vaccines by Type (2020-2031)
Figure 63. Global Animal Vaccines Price (USD/Unit) by Type (2020-2031)
Figure 64. Global Sales Market Share of Animal Vaccines by Application (2020-2031)
Figure 65. Global Revenue Market Share of Animal Vaccines by Application (2020-2031)
Figure 66. Global Animal Vaccines Price (USD/Unit) by Application (2020-2031)
Figure 67. Animal Vaccines Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Our Clients